These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2522398)

  • 21. Combination of 19-nortestosterone-hexyloxyphenylpropionate (Anadur) and depot-medroxyprogesterone-acetate (Clinovir) for male contraception.
    Knuth UA; Yeung CH; Nieschlag E
    Fertil Steril; 1989 Jun; 51(6):1011-8. PubMed ID: 2524404
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endocrine, seminal and peripheral effects of depot medroxyprogesterone acetate and testosterone enanthate in men.
    Hedman M; Gottlieb C; Svanborg K; Bygdeman M; de la Torre B
    Int J Androl; 1988 Aug; 11(4):265-76. PubMed ID: 2971625
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Suppression of human spermatogenesis by testosterone implants.
    Handelsman DJ; Conway AJ; Boylan LM
    J Clin Endocrinol Metab; 1992 Nov; 75(5):1326-32. PubMed ID: 1430094
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Study of medroxyprogesterone acetate and testosterone enanthate as a male contraceptive.
    Brenner PF; Mishell DR; Bernstein GS; Ortiz A
    Contraception; 1977 Jun; 15(6):679-91. PubMed ID: 891194
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of simultaneous gonadotropin-releasing hormone agonist and testosterone treatment on spermatogenesis and potential fertilizing capacity in male monkeys.
    Mann DR; Gould KG; Smith MM; Duffey T; Collins DC
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1215-24. PubMed ID: 3316265
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low dose of cyproterone acetate and testosterone enanthate for contraception in men.
    Meriggiola MC; Bremner WJ; Costantino A; Di Cintio G; Flamigni C
    Hum Reprod; 1998 May; 13(5):1225-9. PubMed ID: 9647551
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potential of testosterone buciclate for male contraception: endocrine differences between responders and nonresponders.
    Behre HM; Baus S; Kliesch S; Keck C; Simoni M; Nieschlag E
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2394-403. PubMed ID: 7543113
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Depot gonadotropin-releasing hormone agonist blunts the androgen-induced suppression of spermatogenesis in a clinical trial of male contraception.
    Behre HM; Nashan D; Hubert W; Nieschlag E
    J Clin Endocrinol Metab; 1992 Jan; 74(1):84-90. PubMed ID: 1727833
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intramuscular testosterone undecanoate and norethisterone enanthate in a clinical trial for male contraception.
    Kamischke A; Venherm S; Plöger D; von Eckardstein S; Nieschlag E
    J Clin Endocrinol Metab; 2001 Jan; 86(1):303-9. PubMed ID: 11232016
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of testosterone plus medroxyprogesterone acetate on semen quality, reproductive hormones, and germ cell populations in normal young men.
    McLachlan RI; O'Donnell L; Stanton PG; Balourdos G; Frydenberg M; de Kretser DM; Robertson DM
    J Clin Endocrinol Metab; 2002 Feb; 87(2):546-56. PubMed ID: 11836283
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rates of suppression and recovery of human sperm output in testosterone-based hormonal contraceptive regimens.
    Ly LP; Liu PY; Handelsman DJ
    Hum Reprod; 2005 Jun; 20(6):1733-40. PubMed ID: 15860500
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined administration of levonorgestrel and testosterone induces more rapid and effective suppression of spermatogenesis than testosterone alone: a promising male contraceptive approach.
    Bebb RA; Anawalt BD; Christensen RB; Paulsen CA; Bremner WJ; Matsumoto AM
    J Clin Endocrinol Metab; 1996 Feb; 81(2):757-62. PubMed ID: 8636300
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Contraceptive efficacy and adverse effects of testosterone enanthate in Thai men.
    Sukcharoen N; Aribarg A; Kriangsinyos R; Chanprasit Y; Ngeamvijawat J
    J Med Assoc Thai; 1996 Dec; 79(12):767-73. PubMed ID: 9071080
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of two androgens plus depot-medroxyprogesterone acetate for suppression to azoospermia in indonesian men. World Health Organization. Task Force on Methods for the Regulation of Male Fertility.
    Fertil Steril; 1993 Dec; 60(6):1062-8. PubMed ID: 8243687
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spermatogenetic inhibition in men taking a combination of oral medroxyprogesterone acetate and percutaneous testosterone as a male contraceptive method.
    Soufir JC; Meduri G; Ziyyat A
    Hum Reprod; 2011 Jul; 26(7):1708-14. PubMed ID: 21551452
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intramuscular testosterone undecanoate with or without oral levonorgestrel: a randomized placebo-controlled feasibility study for male contraception.
    Kamischke A; Plöger D; Venherm S; von Eckardstein S; von Eckardstein A; Nieschlag E
    Clin Endocrinol (Oxf); 2000 Jul; 53(1):43-52. PubMed ID: 10931079
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of spermatogenesis in men with monthly injections of medroxyprogesterone acetate and testosterone enanthate.
    Melo JF; Coutinho EM
    Contraception; 1977 Jun; 15(6):627-34. PubMed ID: 891190
    [No Abstract]   [Full Text] [Related]  

  • 38. Comparison of a gonadotropin releasing-hormone antagonist plus testosterone (T) versus T alone as potential male contraceptive regimens.
    Bagatell CJ; Matsumoto AM; Christensen RB; Rivier JE; Bremner WJ
    J Clin Endocrinol Metab; 1993 Aug; 77(2):427-32. PubMed ID: 8345047
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contraceptive efficacy of testosterone-induced azoospermia in normal men. World Health Organization Task Force on methods for the regulation of male fertility.
    Lancet; 1990 Oct; 336(8721):955-9. PubMed ID: 1977002
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Attainment and maintenance of azoospermia with combined monthly injections of depot medroxyprogesterone acetate and testosterone enanthate.
    Alvarez-Sanchez F; Faundes A; Brache V; Leon P
    Contraception; 1977 Jun; 15(6):635-48. PubMed ID: 891191
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.